|
" Multiple Risk Factors in Cardiovascular Disease : "
edited by Antonio M. Gotto, C. Lenfant, Rodolfo Paoletti, A.L. Catapano, A.S. Jackson.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
775411
|
| Doc. No
|
:
|
b595406
|
| Main Entry
|
:
|
edited by Antonio M. Gotto, C. Lenfant, Rodolfo Paoletti, A.L. Catapano, A.S. Jackson.
|
| Title & Author
|
:
|
Multiple Risk Factors in Cardiovascular Disease : : Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke\ edited by Antonio M. Gotto, C. Lenfant, Rodolfo Paoletti, A.L. Catapano, A.S. Jackson.
|
| Publication Statement
|
:
|
Dordrecht : Springer Netherlands, 1998
|
| Series Statement
|
:
|
Medical science symposia series, 12.
|
| Page. NO
|
:
|
(xvii, 370 pages)
|
| ISBN
|
:
|
9401150222
|
|
|
:
|
: 9789401150224
|
| Contents
|
:
|
I. Plasma Lipids and Lipoproteins --; New Insights into the Role of HDL in the Development of Cardiovascular Disease --; Mechanisms of the Hypolipidemic Action of Fibrates --; Lipid Lowering Drugs and the Arterial Wall --; Perspectives on Lipid-Lowering Therapy: Past and Present --; II. Coagulation, Fibrinolysis, and Platelet Inhibition --; Role of the Fibrinolytic and the Coagulation System in the Formation and Disorders of Blood Vessels --; Evolving Understanding of Coronary Thrombosis and New Insights into Therapeutic Strategies --; Platelet Activation and Carotid Arterial Atherothrombosis --; III. Emerging Risk Factors for Cardiovascular Disease --; Tissue Factor and the Regulation of Arterial Thrombosis --; Fibrinogen: Risk Factor or Risk Marker? --; PAI-1 and the Risk of Cardiovascular Disease --; Plasma Homocyst(e)ine [H(e)] and Arterial Occlusive Diseases: Gene-Nutrient Interactions --; IV. Risk Factors and Intervention: National Initiatives --; The Role of Social and Psychoemotional Factors in the Development of Cardiovascular Disease: The Experience in Eastern European Countries --; European Action on Secondary Prevention --; Cardiovascular Risk Factors in Normotensive and Hypertensive Egyptians: Preliminary Results, Egyptian National Hypertension Project (NHP) --; V. LDL Oxidation, Antioxidants, and Atherosclerosis --; Lipid Deposition and Oxidation in the Evolution of the Atherosclerotic Lesion: Lessons Learned from Hypercholesterolemic Animal Models --; Oxidative Modification of LDL and Atherogenesis --; Dietary Antioxidants and Cardiovascular Disease --; Is 'Antioxidant Status' a Risk Factor? --; VI. Diabetes --; Diabetes and Atherosclerosis: Risk Factors and Clinical Trials --; Insulin Resistance: What, Why, and How --; Diabetes --; Dyslipidemia, Diabetes, and Cell Adhesion Molecules --; Novel Therapeutic Approaches to Insulin Resistance/Diabetic Dyslipidemia --; VII. Genetic Determinants of Cardiovascular Disease --; Hypertension and Thrombosis, Genetic Determinants of Cardiovascular Disease --; Lipoproteins and Cardiovascular Risk. From Genetics to Prevention of Coronary Heart Disease --; Obesity and Diabetes --; Clustering of Cardiovascular Risk Factors --; VIII. Inflammation and Cardiovascular Disease --; Neutrophil-Endothelial Cells Cooperation in the Handling of Leukotrienes: Role in Coronary Inflammation --; Integrin Expression and Macrophage Resistance to Apoptosis in Atherosclerosis --; IX. From Cholesterol to Cardiovascular Events, Where is the Bridge? --; Effect of Statins Beyond Lowering Cholesterol: Where Do We Stand? --; Lessons from Clinical Trials: LCAS and Other Studies --; Improving the Cost Effectiveness of Lipid Lowering Therapy in Coronary Heart Disease Prevention --; X. Lifestyle and Cardiovascular Disease --; Diet and Cardiovascular Disease --; Alcohol and Coronary Heart Disease: A Comparison of Ecologic and Non-Ecologic Studies --; Preventing Cardiovascular Disease: Effective Smoking Cessation Strategies for the Busy Clinician --; XI. Multiple Risk Factors and Cardiovascular Disease --; Risk Factors for Cardiovascular Disease and the Endothelium --; Epidemiology of Risk Factor Clustering in Elevated Blood Pressure --; Hypertension and Coronary Heart Disease Risk Factor Management --; Global Risk Management: New Strategies for Implementation --; XII. Cardiac Failure --; Sudden Cardiac Death in Heart Failure.
|
| Abstract
|
:
|
The issue of interaction of risk factors in cardiovascular disease is timely and of clinical relevance. This book is a collection of the scientific contributions to the 4th International Symposium on Multiple Risk Factors and Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke, and addresses the role of simultaneous risk factors in patients. Because patients with two or more risk factors are at very high risk for developing cardiovascular diseases, special care should be taken in the choice of appropriate therapeutic intervention. Risk factors are also discussed from the point of view of the biochemist and the pharmacologist by addressing the mechanisms underlying the onset of hypertension, hyperlipoproteinemia, hypercoagulability, and the possibility of therapeutic intervention. This book will therefore be of value to the biochemist, pharmacologist, and clinical pharmacologist, as well as to specialists in the field of cardiovascular medicine in order to keep up-to-date with current knowledge in this fast moving field of research.
|
| Subject
|
:
|
Cardiology.
|
| Subject
|
:
|
Causality.
|
| Subject
|
:
|
Medicine.
|
| LC Classification
|
:
|
RC669.E358 1998
|
| Added Entry
|
:
|
A L Catapano
|
|
|
:
|
A S Jackson
|
|
|
:
|
Antonio M Gotto
|
|
|
:
|
C Lenfant
|
|
|
:
|
Rodolfo Paoletti
|
| |